| Literature DB >> 27983597 |
Lívia Slobodníková1, Silvia Fialová2, Katarína Rendeková3, Ján Kováč4, Pavel Mučaji5.
Abstract
In the history of human medicine, antibiotics represent epochal examples of medical progress. However, with an approaching antibiotic crisis due to the emergence and extensive spread of antimicrobial resistance among bacterial agents, as well as to increasing number of patients with chronic and recalcitrant bacterial biofilm-associated infections, the naturally occurring molecules may become new sources of antibacterial and antibiofilm drugs for clinical usage. Polyphenols represent a class of plant natural products which are important in plant defense against microbial pathogens. The main focus of the review is on the antibiofilm activities of phenolic compounds against bacteria which play an essential role in medical device biofilm-associated infections. The other, not negligible part of the review is devoted to polyphenols' activity against bacterial agents that cause dental caries and periodontal disease.Entities:
Keywords: antibacterial activity; bacterial biofilm; dental caries; medical device-associated infection; periodontal disease; plant polyphenols
Mesh:
Substances:
Year: 2016 PMID: 27983597 PMCID: PMC6273306 DOI: 10.3390/molecules21121717
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Antibiofilm activities of flavonoids, phenolic acids and tannins contained in plant extracts.
| Phenolic Compound | Name of Bacteria | Antibiofilm Activity * | References |
|---|---|---|---|
| ANTHOCYANINS | |||
| Malvidin, Petunidin, Cyanidin | a,b | [ | |
| COUMARINS | |||
| Coumarin | a | [ | |
| a | |||
| a | |||
| a | |||
| Umbelliferone | c | [ | |
| Esculetin | a | [ | |
| a | |||
| Esculin | a | [ | |
| Psoralen | a | [ | |
| Nodakenetin | a | [ | |
| Coladonin | c | [ | |
| FLAVONOIDS | |||
| Chalcone | d | [ | |
| 2′,4′-Dihydroxychalcone | a | [ | |
| 2,2′,4′-Trihydroxychalcone | a | [ | |
| 2′,4′-Dihydroxy-2-methoxychalcone | a | [ | |
| Xanthohumol | a | [ | |
| Naringenin | a | [ | |
| Hesperidin | a | [ | |
| Neohesperidin | a | [ | |
| a | |||
| Neoeriocitrin | a | [ | |
| a | |||
| 8-Prenylnaringenin | a | [ | |
| Apigenin | a | [ | |
| a | |||
| a | |||
| a | |||
| Fisetin | a | [ | |
| Chrysin | a | [ | |
| a | |||
| Luteolin | a | [ | |
| a | |||
| Nobiletin | a, e | [ | |
| Sinensitin | a, e | [ | |
| a, e | |||
| Quercitrin | a | [ | |
| Quercetin | a | [ | |
| a | |||
| a | |||
| a | |||
| Kaempferol | a | [ | |
| a | |||
| a | |||
| Morin | f | [ | |
| Phloretin | g | [ | |
| Rutin | a | [ | |
| Daidzein | a | [ | |
| Genistein | a | [ | |
| a | |||
| TANNINS | |||
| Catechin | a | [ | |
| Gallic acid | a | [ | |
| a | |||
| Methyl gallate | h | [ | |
| a | |||
| (−)-Epigallocatechin gallate | a | [ | |
| a | |||
| a | |||
| a | |||
| a | |||
| Ellagic acid | a | [ | |
| Tannic acid | a | [ | |
| Rosmarinic acid | a | [ | |
| 1,2,3,4,6-Penta- | a | [ |
* a—inhibited biofilm formation; b—inhibited EPS production; c—reductions in biofilm formation; d—sortase-specific oral biofilm inhibition; e—inhibited motility; f—in vitro and in vivo antibiofilm efficacy; g—reduced pathogenic biofilm; no harm to commensal E. coli K-12 biofilm formation; h—inactivated bacteria in biofilm.
Figure 1Chemical structure of (−)-epigallocatechin gallate.
Figure 2Chemical structures of gallic acid (left) and methyl gallate (right).
Figure 3Chemical structure of ellagic acid.
Figure 4Chemical structure of hamamelitannin.
Figure 5Chemical structure of rosmarinic acid.
Figure 6Chemical structures of red wine components: quercetin, fisetin, kaempeferol, apigenin, chrysin and luteolin.
Figure 7Chemical structures of morin (left) and phloretin (right).
Figure 8Chemical structure of xanthohumol.
Figure 9Chemical structures of coumarin (left) and umbelliferone (right).